Opportunity to invest in Agritech Invest Holding BV vertical supply chain
Low-cost Colombian production. High-margin European medical supply.
Cannhill SAS is combining fully licensed Colombian infrastructure with precision greenhouse engineering to serve high-demand medical markets in Europe. Investors participate through direct equity in Agritech Invest Holding BV, the Dutch holding company that owns 100% of both the Colombian production entity and the European distribution entity, combining Latin American cost efficiency with European legal protection and governance.
Next Generation Cultivation Facilities
Leveraging our premier hybrid cultivation technology that replicates indoor environmental precision at a significantly lower operational cost.
Established Global Sales Channels
Immediate market access through existing distribution and marketing networks in Tier-1 medical cannabis jurisdictions, including Germany, the UK, and Australia.
Optimal Microclimate Conditions
Utilizing stable mild temperatures year round, optimal airflow, and high light intensity in a hybrid environment, resulting in premium quality.
Elite Proprietary Genetics
Exclusive in-house cultivars through Paradise Seeds, supplemented by a strategic breeding network to ensure a diverse portfolio of globally trending genetics.
Our Corporate Structure
Agritech Invest Holding BV is the sole holding company of the group, with no parent entity above it, giving investors a single, EU-domiciled entry point into both Colombian production and European distribution.
Agritech Invest Holding BV
Netherlands (Parent Entity)
Primary asset holder, investor entry point, capital management.
Cannhill SAS
Colombia (Manufacturer)
Cultivation, production, export licensing.
Cannhill Global Distribution BV
Netherlands (Distribution)
Pricing, QA/GDP oversight, captures residual profit.
European Medical Markets
Pharmaceutical/agro buyers who pay market price to the NL operating co.
Pre-Development
CompletedLand acquisition, licensing, active pilot production, registered genetics, facility design, construction readiness, cultivation quotas.
Phase 1
Current raiseCommercial hybrid facility, GMP compliant post-harvest infrastructure build, begin exports.
Phase 2
Cashflow fundedSite expansion, commercial export scale, and long term supply agreements.
Investor Information Package
Full financial models, buildout specifications, and valuation terms are available to qualified investors in our Investor Information Package.